Chuntao Tian
Overview
Explore the profile of Chuntao Tian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhu Y, Lv Y, Yao H, Chen Z, Yang W, Tian C, et al.
Pathol Res Pract
. 2024 Dec;
266:155784.
PMID: 39709873
Background: Cervical cancer (CC) is one of the most deadly cancers in women, its current treatments still result in poor outcomes and developing the novel targets and therapeutic strategies are...
2.
Liu Y, Li M, Guo Y, Zhang Z, Du L, Zhang X, et al.
Pathol Res Pract
. 2024 May;
259:155371.
PMID: 38820929
Background: Targeted therapy with combined dabrafenib and trametinib has been proven to provide clinical benefits in patients with BRAF V600E mutation-positive NSCLC. Nevertheless, the treatment strategy for NSCLC patients with...
3.
Cao B, Liu K, Tian C, He H, He S, Chen H, et al.
Pathol Res Pract
. 2024 Jan;
254:155116.
PMID: 38218040
The most prevalent kind of primary brain tumors, gliomas, have a dismal prognosis. Recent advances in the tumor-promoting ability of OTX1 have drawn increasing attention. The overexpression of OTX1 has...
4.
Tian C, Han Z, Wang H, Guo Y, Zhao J, Wang Y, et al.
Minerva Med
. 2023 Aug;
PMID: 37526511
No abstract available.
5.
Ma S, Song L, Bai Y, Wang S, Wang J, Zhang H, et al.
RSC Adv
. 2023 Apr;
13(17):11269-11277.
PMID: 37057265
Exosomes exhibit great potential as novel therapeutics for tissue regeneration, including cell migration and angiogenesis. However, the limited intracellular delivery efficiency of exosomes might reduce their biological effects. Here, exosomes...
6.
Pan L, Zhang L, Deng W, Lou J, Gao X, Lou X, et al.
J Control Release
. 2023 Mar;
357:133-148.
PMID: 36972863
Spleen is an ideal site for initiating and amplifying antigen-specific immune response. However, spleen-selective antigen delivery has limited tumor therapeutic efficacy owing to an inadequate cytotoxic T-cell immune response. In...
7.
Ma Y, Zhao W, Sun P, Deng W, Deng J, Zong H, et al.
Ann Transl Med
. 2023 Jan;
10(24):1372.
PMID: 36660622
Background: Apatinib is approved in China for the treatment of advanced gastric adenocarcinoma that had progressed or relapsed after standard systemic chemotherapy treatments. However, the effectiveness of Apatinib under real-world...
8.
Tian C, Liu Y, Liu Y, Hu P, Xie S, Guo Y, et al.
Pathol Res Pract
. 2022 Nov;
240:154235.
PMID: 36434856
Background: Triple-negative breast cancer (TNBC) is a special kind of breast cancer with strong ability of invasion and metastasis. UCHL1 belongs to the ubiquitin carboxy-terminal hydrolase family and is found...
9.
Wang H, Guo Y, Zhang P, Lin Z, Yang D, Chen J, et al.
Comput Math Methods Med
. 2022 Nov;
2022:2974126.
PMID: 36388159
Background: Hypoxia was considered to be a prognostic indicator in a variety of solid tumors. This study aims at identifying the hypoxia-related genes (HRGs) in breast cancer (BC) and the...
10.
Wu J, Yao F, Li Y, Zhao Z, Liu J, Xu T, et al.
Pathol Res Pract
. 2022 Oct;
239:154168.
PMID: 36244247
Gliomas are common brain tumors with poor prognosis. F-box protein39 (FBXO39) is found to be increased in a variety of malignancies, but its expression in gliomas is unknown. Here, we...